At RemeGen, Ltd., a leading biotech innovator in China, we believe biologics are the future of medicine—and we're ready to take our therapeutic innovations to the global stage. We're aligning our investments in scientific research, manufacturing and commercialization to change the way cancer, autoimmune and eye diseases are treated.
RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biological drugs. We strive to continuously create value through our clinical studies to develop products that meet the unmet clinical needs.
We aim to become a global leader in the bio-pharmaceutical industry.
Company Details
- Employees
- 32
- Address
- 58 Middle Beijing Road, Yantai Economic And Technological Development Zone, Yantai,shandong Province,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.remegen.cn
- HQ
- Yantai, Shandong Province
Remegen荣昌生物 Questions
Remegen荣昌生物's website is http://www.remegen.cn
Remegen荣昌生物's LinkedIn profile is https://cn.linkedin.com/company/remegen%E8%8D%A3%E6%98%8C%E7%94%9F%E7%89%A9
Remegen荣昌生物 has
32 employees.
View email and phone details for 32
employees at Remegen荣昌生物.
Remegen荣昌生物's industry is
Pharmaceutical Manufacturing
Remegen荣昌生物's top competitors are
Ac Immune,
Davinci Motor,
Iksuda Therapeutics,
Innovent Biologics,
Hengrui Pharma,
Beigene,
Nexx Group,
Pyxis Oncology,
Remegen Biosciences,
Bioatla, Inc..
Remegen荣昌生物's categories are Pharmaceutical Manufacturing
